News & Updates

Show Multimedia Only

HPV vaccine uptake remains low in SG despite improved awareness

18 Dec 2025 by

Knowledge of human papillomavirus (HPV) vaccination has improved in Singapore following government efforts to enhance cervical cancer awareness through national campaigns and policy changes. However, this has not translated to an increase in vaccine acceptance rates, according to a study.

HPV vaccine uptake remains low in SG despite improved awareness

18 Dec 2025

Antimicrobial use rises following TNFi initiation in PsA patients

10 Dec 2025

A recent study has noted a temporary increase in antimicrobial use following initiation of tumour necrosis factor inhibitor (TNFi) treatment, with no significant risk in serious infections, among patients with psoriatic arthritis (PsA).

Antimicrobial use rises following TNFi initiation in PsA patients

10 Dec 2025

Nirsevimab cuts RSV burden in newborns

10 Dec 2025 by

A retrospective study from Italy shows an association between nirsevimab prophylaxis and a lower risk of respiratory syncytial virus (RSV) hospitalizations and a milder disease course.

Nirsevimab cuts RSV burden in newborns

10 Dec 2025

Switching to DTG/3TC or continuing B/F/TAF tied to similar virologic efficacy in adults with HIV

04 Dec 2025 by

Switching to dolutegravir/lamivudine (DTG/3TC) or continuing bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) showed comparable virologic efficacy through 96 weeks in adults with HIV infection, according to the DYAD observational, open-label extension (OLE) study presented at IDWeek 2025.

Switching to DTG/3TC or continuing B/F/TAF tied to similar virologic efficacy in adults with HIV

04 Dec 2025

Original New Drug Application Approvals by US FDA (16-31 October 2025)

02 Dec 2025

New drug applications approved by US FDA as of 16-31 October 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2025)

02 Dec 2025

Dengue infection carries increased odds of subsequent neurologic events

29 Nov 2025 by

Acute dengue virus (DENV) infection appears to be associated with an increased likelihood of new-onset neurologic events, although the overall increase appears modest, according to a retrospective study from Singapore.

Dengue infection carries increased odds of subsequent neurologic events

29 Nov 2025

Resistance training may help people with long COVID

28 Nov 2025 by

For individuals with persisting COVID-19 symptoms, a 3-month resistance exercise program appears to yield greater improvements in physical function and psychological well-being compared with usual care alone, as shown in a study.